Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A EHRLICH

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Pharmacology|January 1, 1997
The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarinH Fuder, P Kleist, M Birkel, et al.
Blood|November 15, 2003
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cellsJun Won Lee, Ho Yeon Chung, Lori A Ehrlich, et al.
ALTEX|May 19, 2015
Hazard assessment through hybrid in vitro / in silico approach: The case of zearalenoneVeronika A Ehrlich, Luca Dellafiora, Julie Mollergues, et al.
Annals of the New York Academy of Sciences|July 13, 2006
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expressionVeronica Garcia-Palacios, Ho Yeon Chung, Sun Jin Choi, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Inorganic Chemistry|February 24, 2001
Preparation of polyetherol-appended sulfur porphyrazines and investigations of peripheral metal ion binding in polar solventsL A Ehrlich, P J Skrdla, W K Jarrell, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in manA Ehrlich, H Fuder, M Hartmann, et al.
Experimental Hematology|February 26, 2005
MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cellsYasuo Oba, Jun Won Lee, Lori A Ehrlich, et al.
Current Pharmaceutical Biotechnology|January 31, 2012
DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate statusC Wirth, F Schubert, M Lautenschlager, et al.
Environmental Health Perspectives|December 17, 2008
Inhalative exposure to vanadium pentoxide causes DNA damage in workers: results of a multiple end point studyVeronika A Ehrlich, Armen K Nersesyan, Kambis Atefie, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Pharmacology|January 1, 1997
The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarinH Fuder, P Kleist, M Birkel, et al.
Blood|November 15, 2003
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cellsJun Won Lee, Ho Yeon Chung, Lori A Ehrlich, et al.
ALTEX|May 19, 2015
Hazard assessment through hybrid in vitro / in silico approach: The case of zearalenoneVeronika A Ehrlich, Luca Dellafiora, Julie Mollergues, et al.
Annals of the New York Academy of Sciences|July 13, 2006
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expressionVeronica Garcia-Palacios, Ho Yeon Chung, Sun Jin Choi, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Inorganic Chemistry|February 24, 2001
Preparation of polyetherol-appended sulfur porphyrazines and investigations of peripheral metal ion binding in polar solventsL A Ehrlich, P J Skrdla, W K Jarrell, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in manA Ehrlich, H Fuder, M Hartmann, et al.
Experimental Hematology|February 26, 2005
MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cellsYasuo Oba, Jun Won Lee, Lori A Ehrlich, et al.
Current Pharmaceutical Biotechnology|January 31, 2012
DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate statusC Wirth, F Schubert, M Lautenschlager, et al.
Environmental Health Perspectives|December 17, 2008
Inhalative exposure to vanadium pentoxide causes DNA damage in workers: results of a multiple end point studyVeronika A Ehrlich, Armen K Nersesyan, Kambis Atefie, et al.
Pageof 9